Deutsche Bank downgraded Honeywell to Hold from Buy with a price target of $215, down from $227. The analyst says the single biggest driver of the stock’s underperformance has been Honeywell’s “sub-par” organic growth. It is critical to believe Honeywell can produce top-tier organic growth in order to justify share price outperformance from here, the analyst tells investors in a research note. However, the firm’s analysis “fails to prove that this is a likely outcome.” Deutsche finds it is hard to gain conviction in the company’s second half of 2024 implied revenue ramp. Even if this does materialize, there are better stocks to own in a short-cycle recovery, says the firm.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HON:
- Honeywell price target lowered to $228 from $240 at Wolfe Research
- Honeywell Safety Products issues voluntary recall of eyewash cartridges
- Honeywell price target raised to $222 from $209 at RBC Capital
- Honeywell considering sale of PPE equipment business, Bloomberg reports
- Honeywell price target raised to $232 from $230 at Barclays